Search research articles
Contact Us
Filters
Showing results (491-500 of 596) with videos related to
Page
of 60
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2020
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial
L Paz-Ares, A Spira, D Raben, et al.
The Lancet. Oncology
|
October 18, 2016
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Corey J Langer, Shirish M Gadgeel, Hossein Borghaei, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 14, 2017
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
Stephen J Bagley, Shawn Kothari, Charu Aggarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2018
Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials
D Ross Camidge, Dong-Wan Kim, Marcello Tiseo, et al.
Oncology
|
May 6, 2021
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort
Maria Vassilakopoulou, Minhee Won, Walter J Curran, et al.
JCO Precision Oncology
|
July 27, 2023
Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer
Charu Aggarwal, Melina E Marmarelis, Wei-Ting Hwang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 24, 2023
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation
Nikhil Yegya-Raman, Cole Friedes, Sang Ho Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 22, 2018
Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions
Mehrdad Hefazi, Kimberly J Langer, Nandita Khera, et al.
JAMA Network Open
|
March 10, 2023
Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma
Melina E Marmarelis, Xiao Wang, Leonid Roshkovan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 23, 2019
Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial
Rudolf M Huber, Karin H Hansen, Luis Paz-Ares Rodríguez, et al.
Page
of 60
Search research articles
Search
Showing results (491-500 of 596) with videos related to
Sort By:
Page
of 60
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2020
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial
L Paz-Ares, A Spira, D Raben, et al.
The Lancet. Oncology
|
October 18, 2016
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Corey J Langer, Shirish M Gadgeel, Hossein Borghaei, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 14, 2017
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
Stephen J Bagley, Shawn Kothari, Charu Aggarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2018
Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials
D Ross Camidge, Dong-Wan Kim, Marcello Tiseo, et al.
Oncology
|
May 6, 2021
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort
Maria Vassilakopoulou, Minhee Won, Walter J Curran, et al.
JCO Precision Oncology
|
July 27, 2023
Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer
Charu Aggarwal, Melina E Marmarelis, Wei-Ting Hwang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 24, 2023
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation
Nikhil Yegya-Raman, Cole Friedes, Sang Ho Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 22, 2018
Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions
Mehrdad Hefazi, Kimberly J Langer, Nandita Khera, et al.
JAMA Network Open
|
March 10, 2023
Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma
Melina E Marmarelis, Xiao Wang, Leonid Roshkovan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 23, 2019
Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial
Rudolf M Huber, Karin H Hansen, Luis Paz-Ares Rodríguez, et al.
Page
of 60